5-HT

5-HT(6) receptor Antagonists Non-sulfonyl compounds Pyridine core Serotonin receptor

Journal

Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377

Informations de publication

Date de publication:
15 Nov 2023
Historique:
received: 30 08 2023
revised: 01 10 2023
accepted: 02 10 2023
medline: 27 11 2023
pubmed: 9 10 2023
entrez: 8 10 2023
Statut: ppublish

Résumé

In this study, we present the discovery and pharmacological characterization of a new series of 6-piperazinyl-7-azaindoles. These compounds demonstrate potent antagonism and selectivity against the 5-HT

Identifiants

pubmed: 37806499
pii: S0960-894X(23)00375-X
doi: 10.1016/j.bmcl.2023.129497
pii:
doi:

Substances chimiques

serotonin 6 receptor 0
Pyridines 0
VP1-001 0
Serotonin Antagonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

129497

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Michał Gałęzowski (M)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland. Electronic address: michal.galezowski@ryvu.com.

Charles-Henry Fabritius (CH)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland.

Ullamari Pesonen (U)

Orion Corporation, Orion Pharma, Orionintie 1A, 02200 Espoo, Finland.

Harri Salo (H)

Orion Corporation, Orion Pharma, Orionintie 1A, 02200 Espoo, Finland.

Marta Olszak-Płachta (M)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland.

Klaudia Czerwińska (K)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland.

Justyna Adamczyk (J)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland.

Marcin Król (M)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland.

Peteris Prusis (P)

Orion Corporation, Orion Pharma, Orionintie 1A, 02200 Espoo, Finland.

Magdalena Sieprawska-Lupa (M)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland.

Maciej Mikulski (M)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland.

Katja Kuokkanen (K)

Orion Corporation, Orion Pharma, Orionintie 1A, 02200 Espoo, Finland.

Radosław Obuchowicz (R)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland.

Timo Korjamo (T)

Orion Corporation, Orion Pharma, Orionintie 1A, 02200 Espoo, Finland.

Niina Jalava (N)

Orion Corporation, Orion Pharma, Orionintie 1A, 02200 Espoo, Finland.

Agnieszka Nikiforuk (A)

Department of Behavioral Neuroscience and Drug Development, Maj Institute of Pharmacology Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.

Mateusz Nowak (M)

Ryvu Therapeutics S.A., Sternbacha Street 2, 30-394 Kraków, Poland.

Articles similaires

Animals Juvenile Hormones Pyridines Moths Female
Connective Tissue Growth Factor Animals Extracellular Matrix Proteins Humans Liver Cirrhosis

Metabolic engineering of

Jae Sung Cho, Zi Wei Luo, Cheon Woo Moon et al.
1.00
Corynebacterium glutamicum Metabolic Engineering Dicarboxylic Acids Pyridines Pyrones
1.00
Carcinoma, Hepatocellular Liver Neoplasms Proto-Oncogene Proteins c-met Animals Humans

Classifications MeSH